Donaldson Co. Inc. reported its third quarter fiscal 2025 financial results, highlighting record sales of $940.1 million, a 1.3% increase compared to the previous year, driven by pricing benefits and volume growth. The company's GAAP net earnings were $57.8 million, down from $113.5 million in the same period last year. Earnings per share $(EPS)$ were $0.48, compared to $0.92 in 2024. These results included $65.8 million of pre-tax, non-recurring net charges, notably $62.0 million for the impairment of certain intangible assets related to two upstream bioprocessing businesses. Excluding these charges, adjusted net earnings stood at $118.9 million, reflecting a 4.8% increase from the prior year, with an adjusted EPS of $0.99, marking a 7.6% increase versus 2024. The company also announced an 11% increase in its quarterly dividend and accelerated its share repurchase to 3.3% of outstanding shares year-to-date. Looking ahead, Donaldson expects to achieve record sales and adjusted earnings for the full year. The company anticipates the net impact on earnings from current tariffs will be immaterial due to its region-for-region footprint and streamlined decision-making processes. Donaldson plans capital expenditures between $75 million and $90 million, and forecasts an adjusted free cash flow conversion between 80% and 90%. It also expects to repurchase between 3.5% and 4.0% of its shares outstanding this year.